Certain types of cancer treatments can result in the body having too few platelets, a condition called thrombocytopenia, which can increase the risk of bleeding.
Looking back at my experience with osteosarcoma, I realized that managing the mental game was half the battle, especially with so much negativity.
Michael J. Mauro, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).
Reduce breast cancer risk through diet and lifestyle.
Remembering and honoring his mother’s memory, a son recalls one of her last days.
If your chair was cold, I knew you were two floors down in the NICU cradling your only child – the only one I’d be able to give you – making sure his IV and nutrition lines were also connected and beeping lively and skipping at the same beat as mine.
Despite the initial shock and challenges, I found strength and support within the community of single parents.
MY WIFE passed away on Feb. 2, 2014, from a six-year battle with cancer. It is my honor to nominate one angel in particular who, in the end, became much more than a nurse to my wife.
An Extraordinary Healer essay honoring Carol Mallon, RN, MS, OCN [ Penn State Hershey Medical Center Cancer Institute in Hershey, Pennsylvania ]
An Extraordinary Healer essay honoring Debbie Cherry, LPN [ St. Jude Children's Research Hospital in Memphis, Tennessee ]
Bruton tyrosine kinase inhibitors have changed the space for treating patients with CLL or SLL, with more on the way to potentially address drug resistance.
This month’s Research Spotlight highlights significant advancements in pancreatic cancer research and patient support.
Superior progression-free survival (PFS) was seen in patients with ovarian cancer who previously had a partial response (PR) to platinum-based therapy when they took Zejula (niraparib). This response was seen in patients with or without germline BRCA mutations, according to data from the ENGOT-OV16/NOVA trial presented at the 2017 ASCO Annual Meeting.
This essay was written by her colleagues, Jeanine Gordon and Jaclyn Andronico, Memorial Sloan Kettering Cancer Center, nominating Lisa Klempner, M.S.N., RN, OCN for CURE®’s 2019 Extraordinary Healer® Award.
It can be challenging and confusing to get prescription drugs paid for in Canada. Drug access navigators can help.
It's been 17 years since my diagnosis of stage 3a non–small cell lung cancer. I can remember that moment as if it was yesterday.
An Extraordinary Healer essay honoring Debbie O’Sullivan, RN, OCN [UT Health Northeast Cancer Treatment and Prevention Center in Tyler, Texas]
Chemotherapy and PARP inhibitors may share some side effects, but there are some major differences between the two when it comes to treating ovarian cancer.
A prostate cancer survivor offers his thoughts on what you should (and shouldn't) say to someone who was recently diagnosed.